Public Perspectives on COVID-19 Vaccine Prioritization | Vaccination | JN Learning | AMA Ed Hub [Skip to Content]
[Skip to Content Landing]

Public Perspectives on COVID-19 Vaccine Prioritization

Educational Objective
To identify the key insights or developments described in this article
1 Credit CME
Key Points

Question  Which groups does the public believe should be prioritized for COVID-19 vaccine access?

Findings  In this survey study of 4735 US adults, respondents of all demographic and political affiliations agreed with prioritizing health care workers, adults of any age with serious comorbid conditions, frontline workers (eg, teachers and grocery workers), and Black, Hispanic, Native American, and other communities that have been disproportionately affected by COVID-19. Older adult respondents were less likely than younger respondents to list healthy people older than 65 years as 1 of their top 4 priority groups.

Meaning  These findings suggest that the US public agrees with the high-priority groups proposed by the National Academies of Science, Engineering, and Medicine but appears to disagree with approaches advanced by others that prioritize older adults but not essential workers or disproportionately affected communities.

Abstract

Importance  As COVID-19 vaccine distribution continues, policy makers are struggling to decide which groups should be prioritized for vaccination.

Objective  To assess US adults’ preferences regarding COVID-19 vaccine prioritization.

Design, Setting, and Participants  This survey study involved 2 independent, online surveys of US adults aged 18 years and older, 1 conducted by Gallup from September 14 to 27, 2020, and the other conducted by the COVID Collaborative from September 19 to 25, 2020. Samples were weighted to reflect sociodemographic characteristics of the US population.

Exposures  Respondents were asked to prioritize groups for COVID-19 vaccine and to rank their prioritization considerations.

Main Outcomes and Measures  The study assessed prioritization preferences and agreement with the National Academies of Science, Engineering, and Medicine’s Preliminary Framework for Equitable Allocation of COVID-19 Vaccine.

Results  A total of 4735 individuals participated, 2730 (1474 men [54.1%]; mean [SD] age, 59.2 [14.5] years) in the Gallup survey and 2005 (944 men [47.1%]; 203 participants [21.5%] aged 55-59 years) in the COVID Collaborative survey. In both the Gallup COVID-19 Panel and COVID Collaborative surveys, respondents listed health care workers (Gallup, 93.6% [95% CI, 91.2%-95.3%]; COVID Collaborative, 80.0% [95% CI, 78.0%-81.9%]) and adults of any age with serious comorbid conditions (Gallup, 78.6% [95% CI, 75.2%-81.7%]; COVID Collaborative, 72.9% [95% CI, 70.7%-74.9%]) among their 4 highest priority groups. Respondents of all political affiliations agreed with prioritizing Black, Hispanic, Native American, and other communities that have been disproportionately affected by COVID-19 (Gallup, 74.2% [95% CI, 70.6%-77.5%]; COVID Collaborative, 84.9% [95% CI, 83.1%-86.5%]), and COVID Collaborative respondents were willing to be preceded in line by teachers and childcare workers (92.5%; 95% CI, 91.2%-93.7%) and grocery workers (85.9%; 95% CI, 84.2%-87.5%). Older respondents in both surveys were significantly less likely than younger respondents to prioritize healthy adults aged 65 years and older among their 4 highest priority groups (Gallup, 23.7% vs 39.1% [χ2 = 2160.8; P < .001]; COVID Collaborative, 23.3% vs 28.8% [χ2 = 5.0198; P = .03]). COVID Collaborative respondents believed the 4 most important considerations for prioritization were preventing COVID-19 spread (78.4% [95% CI, 76.3%-80.3%]), preventing the most deaths (72.1% [95% CI, 69.9%-74.2%]), preventing long-term complications (68.9% [66.6%-71.9%]), and protecting frontline workers (63.8% [95% CI, 61.5%-66.1%]).

Conclusions and Relevance  US adults broadly agreed with the National Academies of Science, Engineering, and Medicine’s prioritization framework. Respondents endorsed prioritizing racial/ethnic communities that are disproportionately affected by COVID-19, and older respondents were significantly less likely than younger respondents to endorse prioritizing healthy people older than 65 years. This provides reason for caution about COVID-19 vaccine distribution plans that prioritize healthy adults older than a cutoff age without including those younger than that age with preexisting conditions, that aim solely to prevent the most deaths, or that give no priority to frontline workers or disproportionately affected communities.

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

Article Information

Accepted for Publication: March 7, 2021.

Published: April 9, 2021. doi:10.1001/jamanetworkopen.2021.7943

Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Persad G et al. JAMA Network Open.

Corresponding Author: Ezekiel J. Emanuel, MD, PhD, Department of Medical Ethics and Health Policy, University of Pennsylvania Perelman School of Medicine, 423 Guardian Dr, Philadelphia, PA 19104 (zemanuel@upenn.edu).

Author Contributions: Drs Emanuel and Sangenito had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Persad, Emanuel, Glickman, Largent.

Acquisition, analysis, or interpretation of data: All authors.

Drafting of the manuscript: Persad, Glickman, Phillips, Largent.

Critical revision of the manuscript for important intellectual content: Persad, Emanuel, Sangenito, Glickman, Largent.

Statistical analysis: Sangenito.

Obtained funding: Emanuel.

Administrative, technical, or material support: Glickman, Phillips.

Conflict of Interest Disclosures: Dr Persad reported receiving grants from Greenwall Foundation and personal fees from ASCO Post and the World Health Organization outside the submitted work. Dr Emanuel reported being a partner at ReCovery Partners, LLC, Oak HC/FT, and Embedded Healthcare, LLC; receiving personal fees from Center for Neurodegenerative Disease Research, Genentech Oncology, Council of Insurance Agents and Brokers, America’s Health Insurance Plans, Montefiore Physician Leadership Academy, Greenwall Foundation, Medical Home Network, Healthcare Financial Management Association, Ecumenical Center–UT Health, American Academy of Optometry, Associação Nacional de Hospitais Privados, National Alliance of Healthcare Purchaser Coalitions, Optum Labs, Massachusetts Association of Health Plans, District of Columbia Hospital Association, Washington University, Brown University, McKay Lab, American Society for Surgery of the Hand, Association of American Medical Colleges, America’s Essential Hospitals, Johns Hopkins University, National Resident Matching Program, Shore Memorial Health System, Tulane University, Oregon Health & Science University, United Health Group, CBI, and Blue Cross Blue Shield; and receiving nonfinancial support (travel reimbursement) from the Center for Global Development, The Atlantic, RAND Corporation, and Goldman Sachs outside the submitted work. Dr Glickman reported receiving a gift from the Colton Foundation during the conduct of the study. Dr Largent reported receiving grants from the National Institute on Aging and the Greenwall Foundation outside the submitted work. No other disclosures were reported.

Funding/Support: This work was funded in part with a gift from the Colton Foundation.

Role of the Funder/Sponsor: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

References
1.
US Food and Drug Administration. FDA takes key action in fight against COVID-19 by issuing emergency use authorization for first COVID-19 vaccine. Published December 11, 2020. Accessed March 11, 2021. https://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19
2.
Gayle  H , Foege  W , Brown  L , Kahn  B .  Framework for Equitable Allocation of COVID-19 Vaccine. National Academies Press, 2020. doi:10.17226/25917
3.
Dooling  K , McClung  N , Chamberland  M ,  et al.  The Advisory Committee on Immunization Practices’ interim recommendation for allocating initial supplies of COVID-19 vaccine—United States, 2020.   MMWR Morb Mortal Wkly Rep. 2020;69(49):1857-1859. doi:10.15585/mmwr.mm6949e1PubMedGoogle ScholarCrossref
4.
Branswell  H . Adults over 75, frontline essential workers should be in second Covid-19 vaccine priority group, says CDC advisory panel. STAT. Published December 20, 2020. Accessed March 11, 2021. https://www.statnews.com/2020/12/20/adults-over-75-frontline-essential-workers-should-be-in-second-covid-19-vaccine-priority-group-says-cdc-advisory-panel/
5.
Dooling  K , Marin  M , Wallace  M ,  et al.  The Advisory Committee on Immunization Practices’ updated interim recommendation for allocation of COVID-19 vaccine—United States, December 2020.   MMWR Morb Mortal Wkly Rep. 2021;69(5152):1657-1660. doi:10.15585/mmwr.mm695152e2PubMedGoogle ScholarCrossref
6.
O'Donnell  T . Texas veers away from national vaccination guidelines, will prioritize over 65 age group before essential workers. Yahoo! News. Published December 21, 2020. Accessed March 11, 2021. https://news.yahoo.com/texas-veers-away-national-vaccination-214900507.html
7.
Kates  J , Michaud  J , Tolbert  J . How are states prioritizing who will get the COVID-19 vaccine first? Kaiser Family Foundation. Published December 14, 2020. Accessed March 11, 2021. https://www.kff.org/policy-watch/how-are-states-prioritizing-who-will-get-the-covid-19-vaccine-first/
8.
Fonseca  F . Indian Health Service plans for COVID vaccine distribution. AP News. Published December 11, 2020. Accessed March 11, 2021. https://apnews.com/article/health-coronavirus-pandemic-native-americans-808e8b21c995849aaa9ba54efe9911aa
9.
Kates  J , Tolbert  J , Michaud  J . The COVID-19 “vaccination line”: an update on state prioritization plans. Kaiser Family Foundation. Published January 11, 2021. Accessed March 17, 2021. https://www.kff.org/coronavirus-covid-19/issue-brief/the-covid-19-vaccination-line-an-update-on-state-prioritization-plans/
10.
Rabin  RC . Prisons are Covid-19 hotbeds: when should inmates get the vaccine? The New York Times. Published December 2, 2020. Accessed March 11, 2021. https://www.nytimes.com/2020/11/30/health/coronavirus-vaccine-prisons.html
11.
Schmidt  H , Gostin  LO , Williams  MA .  Is it lawful and ethical to prioritize racial minorities for COVID-19 vaccines?   JAMA. 2020;324(20):2023-2024. doi:10.1001/jama.2020.20571PubMedGoogle ScholarCrossref
12.
Cohen  J . Makers of successful COVID-19 vaccines wrestle with options for placebo recipients. Science. December 22, 2020. Accessed March 11, 2021. https://www.sciencemag.org/news/2020/12/makers-successful-covid-19-vaccine-wrestle-options-many-thousands-who-received-placebos
13.
Sugarman  J , Sulmasy  DP .  Methods in Medical Ethics. 2nd ed. Georgetown University Press; 2010.
14.
Persad  G . Public preferences about fairness and the ethics of allocating scarce medical interventions. In: Li  M , Tracer  DP , eds.  Interdisciplinary Perspectives on Fairness, Equity, and Justice: Springer; 2017:51-65.
15.
Gollust  SE , Saloner  B , Hest  R , Blewett  LA .  US adults’ preferences for public allocation of a vaccine for coronavirus disease 2019.   JAMA Netw Open. 2020;3(9):e2023020. doi:10.1001/jamanetworkopen.2020.23020PubMedGoogle Scholar
16.
Buckwalter  W , Peterson  A .  Public attitudes toward allocating scarce resources in the COVID-19 pandemic.   PLoS One. 2020;15(11):e0240651. doi:10.1371/journal.pone.0240651PubMedGoogle Scholar
17.
Wilkinson  D , Zohny  H , Kappes  A , Sinnott-Armstrong  W , Savulescu  J .  Which factors should be included in triage? an online survey of the attitudes of the UK general public to pandemic triage dilemmas.   BMJ Open. 2020;10(12):e045593. doi:10.1136/bmjopen-2020-045593PubMedGoogle Scholar
18.
World Health Organization. WHO SAGE roadmap for prioritizing uses of COVID-19 vaccines in the context of limited supply. Published November 13, 2020. Accessed March 17, 2021. https://www.who.int/publications/m/item/who-sage-roadmap-for-prioritizing-uses-of-covid-19-vaccines-in-the-context-of-limited-supply
19.
Kaiser Family Foundation. State COVID-19 vaccine priority populations. Published February 15, 2021. Accessed March 17, 2021. https://www.kff.org/other/state-indicator/state-covid-19-vaccine-priority-populations/
20.
Levin  AT , Hanage  WP , Owusu-Boaitey  N , Cochran  KB , Walsh  SP , Meyerowitz-Katz  G .  Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications.   Eur J Epidemiol. 2020;35(12):1123-1138. doi:10.1007/s10654-020-00698-1PubMedGoogle ScholarCrossref
21.
Samuels  A . Dan Patrick says “there are more important things than living and that’s saving this country.” The Texas Tribune. Published April 21, 2020. Accessed March 11, 2021. https://www.texastribune.org/2020/04/21/texas-dan-patrick-economy-coronavirus/
22.
Zinberg  JM . Commentary: we don’t need government mandates for Covid vaccination. The Wall Street Journal. Published November 12, 2020. Accessed March 11, 2021. https://www.wsj.com/articles/we-dont-need-government-mandates-for-covid-vaccination-11605222059
23.
Arrazola  J , Masiello  MM , Joshi  S ,  et al.  COVID-19 mortality among American Indian and Alaska Native persons—14 states, January-June 2020.   MMWR Morb Mortal Wkly Rep. 2020;69(49):1853-1856. doi:10.15585/mmwr.mm6949a3PubMedGoogle ScholarCrossref
24.
Joffe  S .  Evaluating SARS-CoV-2 vaccines after emergency use authorization or licensing of initial candidate vaccines.   JAMA. 2021;325(3):221-222. doi:10.1001/jama.2020.25127Google ScholarCrossref
25.
McClung  N , Chamberland  M , Kinlaw  K ,  et al.  The Advisory Committee on Immunization Practices’ ethical principles for allocating initial supplies of COVID-19 vaccine—United States, 2020.   MMWR Morb Mortal Wkly Rep. 2020;69(47):1782-1786. doi:10.15585/mmwr.mm6947e3PubMedGoogle ScholarCrossref
26.
Levinson  M , Cevik  M , Lipsitch  M .  Reopening primary schools during the pandemic.   N Engl J Med. 2020;383(10):981-985. doi:10.1056/NEJMms2024920PubMedGoogle ScholarCrossref
27.
Stanley-Becker  I , Sun  LH . Covid-19 is devastating communities of color: can vaccines counter racial inequity? The Washington Post. Published December 18, 2020. Accessed March 11, 2021. https://www.washingtonpost.com/health/2020/12/18/covid-vaccine-racial-equity/
28.
US White House. National strategy for the COVID-19 response and pandemic preparedness. Published January 21, 2021. Accessed March 17, 2021. https://www.whitehouse.gov/wp-content/uploads/2021/01/National-Strategy-for-the-COVID-19-Response-and-Pandemic-Preparedness.pdf
29.
Marcelo  P . 2 Hard-hit cities, 2 diverging fates in vaccine rollout. The Associated Press. Published February 23, 2021. Accessed March 17, 2021. https://apnews.com/article/rhode-island-immigration-coronavirus-pandemic-massachusetts-coronavirus-vaccine-d489ea9ce71a92155bd873a5e5e970d8
30.
Rushing  E . Black Doctors COVID-19 Consortium will host Philadelphia’s first 24-hour, walk-up vaccination site. The Philadelphia Inquirer. Published February 18, 2021. Accessed March 17, 2021. https://www.inquirer.com/health/coronavirus/philadelphia-coronavirus-vaccine-24-hour-site-black-doctors-covid-consortium-20210218.html
31.
Minnesota Department of Public Health. Minnesota guidance for allocating and prioritizing COVID-19 vaccine—phase 1a. Published March 10, 2021. Accessed March 17, 2021. https://www.health.state.mn.us/diseases/coronavirus/vaccine/phase1aguide.pdf
32.
Persad  G . Allocating medicine fairly in an unfair pandemic. University of Illinois Law Review. Published September 28, 2020. Accessed March 17, 2021. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3699769
33.
Bion  XS . When inequity gets measured, it gets managed. California Health Care Foundation. Published October 19, 2020. Accessed March 11, 2021. https://www.chcf.org/blog/when-inequity-gets-measured-it-gets-managed/
34.
Castillo v. Whitmer. US Court of Appeals, 6th Circuit. Published September 2, 2020. Accessed March 11, 2021. https://www.law360.com/articles/1307160/attachments/0
35.
Slevin  C , Nieberg  P . Inmates in Colorado, across the U.S. facing big coronavirus risks are not atop vaccine lists. The Colorado Sun. Published December 16, 2020. Accessed March 11, 2021. https://coloradosun.com/2020/12/16/coronavirus-colorad-prison-vaccine-list/
36.
Awad  E , Dsouza  S , Kim  R ,  et al.  The Moral Machine experiment.   Nature. 2018;563(7729):59-64. doi:10.1038/s41586-018-0637-6PubMedGoogle ScholarCrossref
37.
Neuberger  J , Adams  D , MacMaster  P , Maidment  A , Speed  M .  Assessing priorities for allocation of donor liver grafts: survey of public and clinicians.   BMJ. 1998;317(7152):172-175. doi:10.1136/bmj.317.7152.172PubMedGoogle ScholarCrossref
38.
Persad  G , Peek  ME , Emanuel  EJ .  Fairly prioritizing groups for access to COVID-19 vaccines.   JAMA. 2020;324(16):1601-1602. doi:10.1001/jama.2020.18513PubMedGoogle ScholarCrossref
39.
Rid  A , Lipsitch  M , Miller  FG .  The ethics of continuing placebo in SARS-CoV-2 vaccine trials.   JAMA. 2021;325(3):219-220. doi:10.1001/jama.2020.25053PubMedGoogle ScholarCrossref
40.
Bassett  MT , Chen  JT , Krieger  N .  Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: a cross-sectional study.   PLoS Med. 2020;17(10):e1003402. doi:10.1371/journal.pmed.1003402PubMedGoogle Scholar
41.
Wortham  JM , Lee  JT , Althomsons  S ,  et al.  Characteristics of persons who died with COVID-19—United States, February 12-May 18, 2020.   MMWR Morb Mortal Wkly Rep. 2020;69(28):923-929. doi:10.15585/mmwr.mm6928e1PubMedGoogle ScholarCrossref
42.
Jiménez  MC , Cowger  TL , Simon  LE , Behn  M , Cassarino  N , Bassett  MT .  Epidemiology of COVID-19 among incarcerated individuals and staff in Massachusetts jails and prisons.   JAMA Netw Open. 2020;3(8):e2018851. doi:10.1001/jamanetworkopen.2020.18851PubMedGoogle Scholar
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
Close
With a personal account, you can:
  • Track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
jn-learning_Modal_SaveSearch_NoAccess_Purchase
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close